A pilot study on using urinary 1-hydroxypyrene biomarker for exposure to PAHs in Beijing

To study whether the urinary 1-hydroxypyrene (1-OHP) could be the biomarker of atmospheric PAHs, a small-scale pilot study was carried out on the relation of 1-OHP vs PAHs with the traffic policemen in Beijing of smokers and nonsmokers to be subgroups in both the exposure and control groups. Both the PAHs and 1-OHP were analyzed with high performance liquid chromatography (HPLC). The ambient concentrations of PAHs were different at the different sites (the average sum of PAHs (TPAH) were 12.36, 16.27, 18.37 ng/m(3) at the suburban residential, police station and high traffic area, respectively.), but considerably lower than the personal-exposure concentrations (the average TPAH were 65.84 and 47.28 ng/m(3) for patrol cars and inspection station, respectively). Pyrene was correlated well with BaP and the summed PAHs (TPAH), with the correlation coefficients (R) of 0.79, 0.87 for ambient level and 0.92, 0.96 for personal exposure, respectively. The average of 1-hydroxypyrene of smokers and nonsmokers were 0.39, 0.15 mu molmol creatinine in control group and 0.57, 0.33 mu mol/mol creatinine in exposure group, respectively. The better correlation of pyrene to BaP and TPAH especially for personal exposure samples indicated that the probability of urinary 1-hydroxypyrene, the metabolite of pyrene, to be the biomarker of total PAH. Nonsmokers in the exposure and control groups had indistinguishable levels of 1-OHP, presumably because the ambient levels of pyrene were so similar (the average were 3.25, 3.20 ng/m(3) at the police station and high traffic area, respectively.). Smokers in the control group had significantly higher 1-OHP than that of the nonsmokers, but showed indistinguishable differences in the exposure group. These results suggested that urinary 1-OHP could be a biomarker of PAHs only when the level of PAHs was at a relatively higher level. Smoking as an important influencing factor need to be controlled carefully.